Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mevlut Ozgur Taskapilioglu

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Turkish Neurosurgery|May 12, 2021
Comparison of Clinical and Molecular Wnt and SHH Subgroups in Medulloblastoma Tumor CasesIsmail Seckin Kaya, Secil Aksoy, Melis Mutlu, et al.
Neurological Research|July 2, 2021
Coexistence of TERT C228T mutation and MALAT1 dysregulation in primary glioblastoma: new prognostic and therapeutic targetsSecil Ak Aksoy, Melis Mutlu, Berrin Tunca, et al.
Bosnian Journal of Basic Medical Sciences|September 4, 2019
Long noncoding RNA MALAT1 may be a prognostic biomarker in IDH1/2 wild-type primary glioblastomasOmer Gokay Argadal, Melis Mutlu, Secil Ak Aksoy, et al.
International Journal of Biological Macromolecules|September 6, 2023
Co-loading of Temozolomide with Oleuropein or rutin into polylactic acid core-shell nanofiber webs inhibit glioblastoma cell by controlled releaseMelis Ercelik, Cagla Tekin, Fatma Nur Parin, et al.
Pediatric Neurosurgery|March 21, 2021
NEAT1 Is a Novel Oncogenic LncRNA and Correlated with miR-143 in Pediatric OligodendrogliomasSecil Ak Aksoy, Melis Mutlu, Rabia Nur Balcin, et al.
Cellular and Molecular Neurobiology|September 13, 2014
Ficus carica latex prevents invasion through induction of let-7d expression in GBM cell linesGulcin Tezcan, Berrin Tunca, Ahmet Bekar, et al.
Asian Journal of Pharmaceutical Sciences|December 6, 2024
A new nano approach to prevent tumor growth in the local treatment of glioblastoma: Temozolomide and rutin-loaded hybrid layered composite nanofiberMelis Ercelik, Cagla Tekin, Melisa Gurbuz, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Turkish Neurosurgery|May 12, 2021
Comparison of Clinical and Molecular Wnt and SHH Subgroups in Medulloblastoma Tumor CasesIsmail Seckin Kaya, Secil Aksoy, Melis Mutlu, et al.
Neurological Research|July 2, 2021
Coexistence of TERT C228T mutation and MALAT1 dysregulation in primary glioblastoma: new prognostic and therapeutic targetsSecil Ak Aksoy, Melis Mutlu, Berrin Tunca, et al.
Bosnian Journal of Basic Medical Sciences|September 4, 2019
Long noncoding RNA MALAT1 may be a prognostic biomarker in IDH1/2 wild-type primary glioblastomasOmer Gokay Argadal, Melis Mutlu, Secil Ak Aksoy, et al.
International Journal of Biological Macromolecules|September 6, 2023
Co-loading of Temozolomide with Oleuropein or rutin into polylactic acid core-shell nanofiber webs inhibit glioblastoma cell by controlled releaseMelis Ercelik, Cagla Tekin, Fatma Nur Parin, et al.
Pediatric Neurosurgery|March 21, 2021
NEAT1 Is a Novel Oncogenic LncRNA and Correlated with miR-143 in Pediatric OligodendrogliomasSecil Ak Aksoy, Melis Mutlu, Rabia Nur Balcin, et al.
Cellular and Molecular Neurobiology|September 13, 2014
Ficus carica latex prevents invasion through induction of let-7d expression in GBM cell linesGulcin Tezcan, Berrin Tunca, Ahmet Bekar, et al.
Asian Journal of Pharmaceutical Sciences|December 6, 2024
A new nano approach to prevent tumor growth in the local treatment of glioblastoma: Temozolomide and rutin-loaded hybrid layered composite nanofiberMelis Ercelik, Cagla Tekin, Melisa Gurbuz, et al.
Pageof 3